Literature DB >> 21037427

Novel and simple preoperative score predicting complications after liver resection in noncirrhotic patients.

Stefan Breitenstein1, Michelle L DeOliveira, Dimitri A Raptis, Ksenija Slankamenac, Patryk Kambakamba, Jakob Nerl, Pierre-Alain Clavien.   

Abstract

OBJECTIVE: To develop and validate a simple score to predict postoperative complications by severity after liver resection, using readily available preoperative risk factors.
BACKGROUND: Although liver surgery has enjoyed major development with dramatic reduction in mortality rates, the incidence of serious yet nonlethal complications remains high. No scoring system is currently available to identify those patients at higher risk for a complicated course.
METHODS: Complications were prospectively assessed in 615 consecutive noncirrhotic patients undergoing liver resection at the same institution. In randomly selected 60% of the population, multivariate-logistic-regression analysis was used to develop a score to predict severe complications defined as complications grades III, IV, and mortality (grade V) (Clavien-Dindo classification). The score was validated by calibration within the remaining 40% of the patients.
RESULTS: Grades III to V complications occurred in 159 (26%) of the 615 patients after liver resection, 90 (15%) were grade III, 48 (8%) grade IV, and 21 (3%) grade V. Four preoperative parameters were identified as independent predictors including American Society of Anesthesiologists category, transaminases levels (aspartate aminotransferase), extent of liver resection (>3 vs <3 segments), and the need for an additional hepaticojejunostomy or colon resection. A prediction score was calculated on the basis of 60% of the population (369 patients) using the 4 independent predictors ranging from 0 to 10 points. The risk to develop serious postoperative complications was 16% in "low risk" patients (0-2 points), 37% in "intermediate risk" patients (3-5 points) and 60% in "high risk" patients (6-10 points). The predicted mean for absolute risk for grades III to V complications was 27% in the validation population including 40% of the patients (n = 246), whereas the observed risk was 24%. Predicted and observed risks were similar throughout the different risk categories (P = 0.8). The score was significantly associated with hospital and intensive care unit stays. Costs of the entire procedure doubled among the 3 risk groups.
CONCLUSIONS: This novel and simple score accurately predicts postoperative complications and cost in patients undergoing liver resection. This score allows early identification of patients at risk and may impact not only decision making for surgical intervention but also quality assessment and reimbursement.

Entities:  

Mesh:

Year:  2010        PMID: 21037427     DOI: 10.1097/SLA.0b013e3181fb8c1a

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  39 in total

1.  External validation of a pre-operative nomogram predicting peri-operative mortality risk after liver resections for malignancy.

Authors:  Mashaal Dhir; Srinevas K Reddy; Lynette M Smith; Fred Ullrich; James Wallis Marsh; Allan Tsung; David A Geller; Chandrakanth Are
Journal:  HPB (Oxford)       Date:  2011-09-16       Impact factor: 3.647

2.  Proposal of objective morphological classification system for hepatocellular carcinoma using preoperative multiphase computed tomography.

Authors:  Hisashi Nakayama; Tadatoshi Takayama; Takao Okubo; Tokio Higaki; Yutaka Midorikawa; Masamichi Moriguchi; Akiyoshi Itoh
Journal:  J Gastroenterol       Date:  2013-11-16       Impact factor: 7.527

3.  Comparison of the Extent Classification and the New Complexity Classification of Hepatectomy for Prediction of Surgical Outcomes: a Retrospective Cohort Study.

Authors:  Xiao-Long Wu; Zhi-Yu Li; Yong Jiang; Xinyu Bi; Hong Zhao; Jian-Jun Zhao; Zhen Huang; Ye-Fan Zhang; Jian-Qiang Cai
Journal:  J Gastrointest Surg       Date:  2019-02-15       Impact factor: 3.452

4.  Nomogram for individualised prediction of liver failure risk after hepatectomy in patients with resectable hepatocellular carcinoma: the evidence from ultrasound data.

Authors:  Hao Hu; Hong Han; Xi Kun Han; Wen Ping Wang; Hong Ding
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

5.  Abandoning Prophylactic Abdominal Drainage after Hepatic Surgery: 10 Years of No-Drain Policy in an Enhanced Recovery after Surgery Environment.

Authors:  Edgar M Wong-Lun-Hing; Victor van Woerden; Toine M Lodewick; Marc H A Bemelmans; Steven W M Olde Damink; Cornelis H C Dejong; Ronald M van Dam
Journal:  Dig Surg       Date:  2017-03-25       Impact factor: 2.588

6.  Pancreaticoduodenectomy with major vascular resection: a comparison of laparoscopic versus open approaches.

Authors:  Kris P Croome; Michael B Farnell; Florencia G Que; K Marie Reid-Lombardo; Mark J Truty; David M Nagorney; Michael L Kendrick
Journal:  J Gastrointest Surg       Date:  2014-10-02       Impact factor: 3.452

Review 7.  Acute renal injury after partial hepatectomy.

Authors:  Luis Alberto Batista Peres; Luis Cesar Bredt; Raphael Flavio Fachini Cipriani
Journal:  World J Hepatol       Date:  2016-07-28

Review 8.  [Neoadjuvant chemotherapy or primary surgery for colorectal liver metastases. Pro primary surgery].

Authors:  S Heinrich; H Lang
Journal:  Chirurg       Date:  2014-01       Impact factor: 0.955

9.  Are two-stage hepatectomies associated with more complications than one-stage procedures?

Authors:  Erik Schadde; Ksenija Slankamenac; Stefan Breitenstein; Mickael Lesurtel; Michelle De Oliveira; Beatrice Beck-Schimmer; Philipp Dutkowski; Pierre-Alain Clavien
Journal:  HPB (Oxford)       Date:  2012-11-28       Impact factor: 3.647

Review 10.  Assessment of the reporting of quality and outcome measures in hepatic resections: a call for 90-day reporting in all hepatectomy series.

Authors:  Michael E Egger; Joanna M Ohlendorf; Charles R Scoggins; Kelly M McMasters; Robert C G Martin
Journal:  HPB (Oxford)       Date:  2015-07-30       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.